REAL-TIME GLOBAL RESEARCH
2Q26 beat on ECP and backend strength
Research evidence excerpt
Not for redistribution without written consent of Morgan Stanley
M
Update
August 7, 2026 02:27 PM GMT
Morgan Stanley Taiwan Limited+
ACM Research Inc | Asia Pacific
Charlie Chan
Equity Analyst
2Q26 beat on ECP and backend
strength
Morgan Stanley Asia Limited+
Henry Zhao
Research Associate
Morgan Stanley Taiwan Limited+
AlphaSignals Earnings Reaction
Daniel Yen, CFA
Unchanged
Modest upside
Modest revision higher
Impact to our thesis
Financial results versus consensus
Direction of next 12-month
consensus EPS
Source: Company data, Morgan Stanley Research
Equity Analyst
Morgan Stanley Asia Limited+
Daisy Dai, CFA
Equity Analyst
ACMR 2Q26 recap:
• Revenue reached US$293mn, up 27% Q/Q and 36% Y/Y, beating MSe and
consensus, driven by strong ECP and advanced packaging tool growth (in line
with our previous note Backend optionality adds to China memory upside).
• Total shipments were US$282mn, up 36% Y/Y.
• GM rose to 46%, down 0.4ppts Q/Q. Net income to shareholders was US
$89mn, up 414% Q/Q and 199% Y/Y.
Morgan Stanley Taiwan Limited+
Tiffany Yeh
Equity Analyst
Lucas Wang
Research Associate
Morgan Stanley Asia Limited+
Ethan Jia
Outlook on new products. The company delivered 168% and 153% Y/Y growth for
ECP and advanced packaging. Its PECVD and track tools are under customer
Research Associate
qualification, targeting production-ready status by end-2026, unlocking incremental
revenue streams.
Maintain OW: China memory expansion remains the clearest near-term growth
driver, while advanced packaging ECP and broader platform expansion provide
additional upside. We remain constructive on ACMR’s growth runway as it broadens
beyond wet cleaning and gains traction with more clients.
ACM Research Inc (ACMR.O, ACMR US)
Greater China Technology Semiconductors | China
Stock Rating
Industry View
Price target
Up/downside to price target (%)
Shr price, close (Aug 6, 2026)
52-Week Range
Sh out, dil, curr (mn)
Mkt cap, curr (mn)
EV, curr (mn)
Avg daily trading value (mn)
Fiscal Year Ending
Overweight
Attractive
US$130.00
65
US$78.98
US$127.19-23.03
59
US$4,672
US$4,093
US$81
12/25 12/26e 12/27e 12/28e
Morgan Stanley does and seeks to do business with
…
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer